TABLE 1

Details of Patients with Takayasu Arteritis Who Underwent ¹⁸F-FDG PET

Patient no.	Sex	Age (y)	Disease stage	CRP (mg/L)	ESR (mm/h)	FBS (mg/dL)	Maximal SUV*	¹⁸F-FDG site
1	F	17	Active	80	95	110	1.8	As, SC
2	F	27	Active	72	97	91	1.7	Ar, CC
3	F	21	Active	14	88	107	3.5	Ve
4	F	37	Active	21	78	96	2.7	As
5	F	31	Active	11	33	80	2.0	As, Ds
6	M	21	Active	65	24	97	2.3	As
7	F	33	Active	41	94	88	1.8	As
8	F	25	Active	50	85	96	1.9	As
9	F	14	Active	25	45	82	1.2	As
10	F	24	Active	16	85	93	1.9	As, Ds
11	F	21	Active	17	54	138	1.4	CC
12	F	50	Inactive	0	15	99	1.2	As
13	F	39	Inactive	3	49	90	1.2	As
14	F	44	Inactive	0	12	88	1.2	As
Control subjects^†	1 M, 5 F	22–74		Negative	Negative	66–95	1.1 ± 0.2^‡	As

↵* Maximal SUVs were evaluated at highest ¹⁸F-FDG accumulation sites on first PET scan.
↵^† n = 6.
↵^‡ Mean ± SD.
CRP = C-reactive protein; ESR = erythrocyte sedimentation rate; FBS = fasting blood sugar; As = ascending aorta; SC = subclavian arteries; Ar = aortic arch; CC = common carotid arteries; Ve = vertebral arteries; Ds = descending artery.